| Type | Title | Date Released | |
|---|---|---|---|
10-Q | Form 10-Q New | ||
8-K | Neurogene Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Updates for NGN-401 New | ||
SCHEDULE 13G | PRUDENTIAL FINANCIAL INC (Filed by) | ||
SCHEDULE 13G | JENNISON ASSOCIATES LLC (Filed by) | ||
4 | McMinn Rachel (Reporting) | ||
SCHEDULE 13G/A | Redmile Group, LLC (Filed by) | ||
SCHEDULE 13G/A | Trails Edge Capital Partners, LP (Filed by) | ||
SCHEDULE 13G | BALYASNY ASSET MANAGEMENT L.P. (Filed by) | ||
10-Q | Form 10-Q | ||
8-K | Neurogene Reports Second Quarter 2026 Financial Results and Provides Update on NGN-401 Rett Syndrome Program | ||
4 | Cvijic Christine Mikail (Reporting) | ||
4 | Cvijic Christine Mikail (Reporting) |
